• A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma OPEN ENROLLMENT
• A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC who are BCG Naïve/Received Incomplete BCG Treatment OPEN ENROLLMENT
• BCG in combination with durvalumab in adult BCG-naive, high-risk NMIBC participants OPEN ENROLLMENT
• Study of BD ORC Original Absorbable Hemostat Compared with Surgicel® Original Absorbable Hemostat OPEN ENROLLMENT
• A Phase 1 Study of EG-70 as an Intravesical Administration to Patients with BCG -Unresponsive NMIBC OPEN ENROLLMENT